Cited by 232Acute Myocardial Infarction ResearchClinical Laboratory Practices and Quality ControlBiomarkers in Disease Mechanisms

Degradation of cardiac troponin I: implication for reliable immunodetection

Katrukha, Aleksei G, Bereznikova, Anastasia V, Filatov, Vladimir L, Esakova, Tatiana V, Kolosova, Olga V, Pettersson, Kim, Lövgren, Timo, Bulargina, Tamara V +5 more·1998·Clinical Chemistry

Abstract

We have analyzed by different immunological methods the proteolytic degradation of cardiac troponin I (cTnI) in human necrotic tissue and in serum. cTnI is susceptible to proteolysis, and its degradation leads to the appearance of a wide diversity of proteolytic peptides with different stabilities. N- and C-terminal regions were rapidly cleaved by proteases, whereas the fragment located between residues 30 and 110 demonstrated substantially higher stability, possibly because of its protection by TnC. We conclude that antibodies selected for cTnI sandwich immunoassays should preferentially recognize epitopes located in the region resistant to proteolysis. Such an approach can be helpful for a much needed standardization of cTnI immunoassays and can improve the sensitivity and reproducibility of cTnI assays.

Integrity signals

Registry

Crossref · 10.1093/clinchem/44.12.2433

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The peptide targets the central portion of cTnI (amino acid residues 114-144) with less susceptibility to proteolysis.

    “This specific peptide (HWQIAYNEHQWQ) not only exhibits an impressive binding affinity (Kd) of 270 pM comparable to that of antibodies37, but also targets the central portion of cTnI (amino acid residues 114–144) with less susceptibility to proteolysis and is postulated to be an optimal targeting epitope to detect all forms of cTnI present in blood circulation38–40.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Katrukha, A. G., Bereznikova, A. V., Filatov, V. L., Esakova, T. V., Kolosova, O. V., Pettersson, K., Lövgren, T., Bulargina, T. V., Trifonov, I. R., Gratsiansky, N. A., Pulkki, K., Voipio-Pulkki, L.-M., & Gusev, N. B.
Affiliations
  • HyTest (Finland) (FI)
  • Lomonosov Moscow State University (RU)
  • Department of Biotechnology, Institute of Medical Ecology, Simpheropolskiy bull. 8, 113149 Moscow, Russia
  • University of Turku (FI)
  • Department of Biotechnology, University of Turku, Tykistokatu 6A, FIN-20520 Turku, Finland
  • Moscow City Hospital No 29 (RU)
  • Turku University Hospital (FI)
  • Turku University Hospital, Central Laboratory, Kiinanmyllynkaty 4–8, FIN-20520 Turku, Finland
Corresponding author
Katrukha, Aleksei G
Venue
Clinical Chemistry
Published
1998-12-01
Volume
44
Issue
12
Pages
2433-2440
ISSN
  • 0009-9147 (ISSN-L)
  • 1530-8561
OpenAlex
W2148344623
Cited by
232
References
20
Citations by year
2026: 3 · 2025: 7 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 6 · 2019: 3 · 2018: 5 · 2017: 5 · 2016: 5 · 2015: 8 · 2014: 7 · 2013: 6 · 2012: 12
FWCI
10.35
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
  • Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
Keywords
cardiac troponin I, proteolysis, proteolytic peptides, troponin C, epitope stability, sandwich immunoassay, antibody selection, myocardial necrosis, cardiac biomarkers, assay standardization
MeSH terms
Amino Acid Sequence, Antibodies, Monoclonal, Epitopes, Humans, Hydrolysis, Molecular Sequence Data, Myocardial Infarction, Myocardium, Peptide Fragments, Endopeptidases, Sensitivity and Specificity, Time Factors, Blotting, Western, Fluoroimmunoassay, Reproducibility of Results, Troponin T

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review